Digital infrastructure in the COVID-19 age: Data security, rapid scalability and AI for clinical assays and diagnostics

May 21, 2020

In this Cambridge Healthtech Institute webinar, TruGenomix’s Dr. Tshaka Cunningham joins Mike Kubal from BlueBee and Dr. Paul Flook from ChromaCode to discuss assay development and its impact on the COVID-19 pandemic.

Press Contact

Jen Williams
jen@polarisgenomics.com
+1 802 355 5072

Additional Reading

Polaris Genomics Advances Mental Health Biomarker Discovery

September 16, 2025

For decades, psychiatry has struggled with a critical gap: unlike cardiology or oncology, there are no molecular biomarkers to guide diagnosis or treatment. Polaris Genomics was founded to change that, and our mission recently earned global recognition as we progress...

Conference Posters for Review

July 25, 2025

Our scientific team is often invited to present posters at a range of academic, pharma, and clinical research conferences focused on neuroscience and mental and brain health. If you have not been able to meet them in person and see our technical information firsthand,...